Journal
INTERNATIONAL JOURNAL OF NEUROSCIENCE
Volume 131, Issue 1, Pages 56-64Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/00207454.2020.1732974
Keywords
Multiple sclerosis; epigenetic; methylations; modification
Categories
Ask authors/readers for more resources
Multiple sclerosis is a chronic neurodegenerative disease that affects the central nervous system, mostly young adults, with complex epigenetic mechanisms playing a key role in its pathogenesis and potentially serving as therapeutic targets.
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease accompanied by demyelination of neurons in the central nervous system that mostly affects young adults, especially women. This disease has two phases including relapsing-remitting form (RR-MS) by episodes of relapse and periods of clinical remission and secondary-progressive form (SP-MS), which causes more disability. The inheritance pattern of MS is not exactly identified and there is an agreement that it has a complex pattern with an interplay among environmental, genetic and epigenetic alternations. Epigenetic mechanisms that are identified for MS pathogenesis are DNA methylation, histone modification and some microRNAs' alternations. Several cellular processes including apoptosis, differentiation and evolution can be modified along with epigenetic changes. Some alternations are associated with epigenetic mechanisms in MS patients and these changes can become key points for MS therapy. Therefore, the aim of this review was to discuss epigenetic mechanisms that are associated with MS pathogenesis and future therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available